CRISPR interference decision, Center for Intellectual Property Understanding, Alibaba, Section 101, Northern District of California – the week in IP

February 15 2017

The USPTO ruling “no interference in fact” in the CRISPR patents dispute, the unveiling of a new non-profit devoted to increasing awareness of IP rights, Alibaba accusing agencies of filing false complaints, IBM’s Manny Schecter calling for Congress to act on Section 101, and new patent case rules in the Northern District of California were in the intellectual property news in the past week

Unlock this content.

The content you are trying to view is exclusive to our subscribers.

To unlock this content:

Request Access or Login

Topics

more from across site and SHARED ros bottom lb

More from across our site

Weekly take: The wolf huffed and puffed, but Peppa kept it simple

By accepting a relatively small sample of infringing content to grant worldwide relief, a UK court has adopted a pragmatic approach that could reduce the time and expense involved in huge enforcement actions

Max Walters, July 31 2026

Rankings Analysis

2026headers Rankings Release - analysis.png

IP STARS Americas rankings highlight firms’ cross-sector strength

This year’s IP STARS Americas rankings reveal that firms are expanding their capabilities, particularly in trade secrets and life sciences

Sanjana Mishra, July 30 2026

Rankings Analysis

2026headers Rankings Release - anouncement.png

Reaching the summit: IP STARS Americas rankings released

Law firms’ expanding IP capabilities are driving broader industry recognition across a wider range of practice areas

Sanjana Mishra, July 30 2026

Patents

Dynamic blue background with glowing golden arrow ascending, representing success and progress.

UPC update: Boutiques gain momentum | Arnold Ruess, Pentarc and Taylor Wessing feature in busy week

As specialist boutiques challenge traditional firm models, major disputes involving Disney, Ericsson, Siemens and Dolby highlight the firms winning work before the UPC

July 30 2026

Patents

Exclusive: Lumenci bets on damages expertise with senior economic hires

The firm has added two leading damages specialists as it expands beyond technical analysis and deepens its role in the economics of IP litigation

Sanjana Mishra, July 29 2026

Patents

How high-stakes trends are shaping future-readiness of life sciences companies

Josh Seidenfeld, partner at DLA Piper, outlines the emerging legal trends that drive the future of life sciences innovation and how stakeholders can prepare for the future

Josh Seidenfeld, July 29 2026

Trademarks

One Law Partners bets on integrated IP and tech advisory with Minwho merger

South Korea's One Law Partners is combining with boutique firm Minwho Law Group to leverage global expansion of K-content and build a broader offering spanning IP, tech and regulatory advisory work

Sukanya Sarkar, July 28 2026

Trademarks

Practical not pedantic: the IP lawyer as commercial partner

Russell Kennedy's Gina Tresidder on juggling matters, delivering hard truths, and why IP ownership is rarely as simple as people think

July 28 2026

Patents

Clinical LLMs and the boundaries of patentability in the UK and Europe

Attorney Oran Friar and trainee attorney Harry Cunliffe at Reddie & Grose, share that patent filings for clinical LLMs are surging, but success in the UK and Europe hinges on demonstrating technical innovation

Oran Friar, July 27 2026

Patents

UK ‘open for business’ as Tesla wins Supreme Court appeal

Implementers can use the UK courts to seek FRAND terms for patent pool licences

July 27 2026